TD Cowen Maintains Hold on Teladoc Health, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Charles Rhyee maintains a Hold rating on Teladoc Health (TDOC) and lowers the price target from $16 to $15.

April 26, 2024 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TD Cowen maintains a Hold rating on Teladoc Health and lowers the price target from $16 to $15.
The reduction in price target by TD Cowen suggests a bearish outlook on Teladoc Health's short-term price potential, likely influencing investor sentiment negatively. The Hold rating indicates a lack of strong positive catalysts that could drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100